Seqirus Limited, a leading global player in the biopharmaceutical industry, is headquartered in Great Britain. Founded in 2015, Seqirus has rapidly established itself as a key provider of innovative vaccines and immunisation solutions, focusing on influenza and other infectious diseases. With major operational regions across Europe, North America, and Asia-Pacific, the company is dedicated to enhancing public health through its advanced research and development initiatives. Seqirus is renowned for its unique portfolio of products, including cell-based and adjuvanted influenza vaccines, which set new standards in efficacy and safety. The company’s commitment to scientific excellence has positioned it as a trusted partner in the fight against infectious diseases, achieving significant milestones in vaccine development and distribution. As a subsidiary of CSL Limited, Seqirus continues to make strides in the global healthcare landscape, contributing to improved health outcomes worldwide.
We don't have data for Seqirus Limited, but we can show you information about their parent organization instead.
View parent company